Highlights,Kyverna Therapeutics now covered with a new rating initiation,Company reports quarterly results surpassing consensus expectations,Stock performance reviewed within of broader Nasdaq ...

Highlights,Alvotech recorded above expectations in its recent quarterly update,The company continues advancing its biosimilar pipeline across autoimmune, eye, and bone disorder treatments,Stock ...